China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · Real-Time Price · USD
2.100
-0.021 (-1.01%)
Apr 24, 2026, 2:40 PM EDT - Market open

China SXT Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
634431129
Market Cap Growth
-81.87%819.62%14.92%-71.49%-60.18%47.16%
Enterprise Value
-13.8917.09-5.78-10.44-2.1115.24
Last Close Price
2.102.4913.4456.721120.007360.00
PE Ratio
--1.07-0.47-0.32-1.02-9.64
PS Ratio
4.0419.691.931.644.375.98
PB Ratio
0.082.220.270.220.691.79
P/TBV Ratio
6.080.230.110.130.361.66
P/FCF Ratio
--14.60-1.93-21.4155.27-20.26
P/OCF Ratio
--14.61-1.93-40.1542.40-21.70
EV/Sales Ratio
-9.81-3.00-5.29-0.813.19
EV/EBITDA Ratio
--6.582.501.950.43-8.23
EV/EBIT Ratio
--6.372.301.860.41-6.94
EV/FCF Ratio
--7.282.9868.90-10.28-10.81
Debt / Equity Ratio
0.060.060.180.250.120.00
Debt / EBITDA Ratio
-0.14-0.38-1.14-0.70-0.42-0.02
Debt / FCF Ratio
-0.43-0.42-1.37-24.819.94-0.03
Net Debt / Equity Ratio
-0.99-1.11-0.68-0.93-0.82-0.83
Net Debt / EBITDA Ratio
2.406.594.082.542.777.18
Net Debt / FCF Ratio
7.177.294.8789.88-65.499.43
Asset Turnover
0.060.080.070.060.080.17
Inventory Turnover
1.521.692.072.001.442.21
Quick Ratio
4.003.301.501.291.201.05
Current Ratio
4.373.541.601.351.311.25
Return on Equity (ROE)
-49.73%-22.50%-21.65%-38.15%-31.37%-24.71%
Return on Assets (ROA)
-34.91%-11.97%-9.55%-17.77%-14.32%-8.32%
Return on Invested Capital (ROIC)
-1953.49%-98.73%-59.72%-165.50%-109.83%-31.64%
Return on Capital Employed (ROCE)
-46.51%-17.94%-17.18%-35.62%-32.04%-17.30%
Earnings Yield
-142.79%-93.21%-212.63%-313.53%-98.51%-10.38%
FCF Yield
-44.15%-6.85%-51.93%-4.67%1.81%-4.93%
Buyback Yield / Dilution
--1212.67%-224.91%-541.91%-44.50%-132.78%
Total Shareholder Return
--1212.67%-224.91%-541.91%-44.50%-132.78%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q